Claas Baier

Claas Baier

Auto-generated profile, based on publicly available information

Claas Baier

Institute for Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Journal of Hospital Infection
Verified
Journal Article
Closed access
CBC. Baier
C. Baier
SPS. Pirr
S. Pirr
SZS. Ziesing
S. Ziesing
EEE. Ebadi
E. Ebadi
GHG. Hansen
G. Hansen
FBF.-C. Bange
F.-C. Bange

1 June 2020 in American Journal of Infection Control
Verified
Journal Article
Open access
CBClaas Baier
Claas Baier
UAUrs-Vito Albrecht
Urs-Vito Albrecht
EEElla Ebadi
Ella Ebadi
RVRalf-Peter Vonberg
Ralf-Peter Vonberg
RSReinhard Schilke
Reinhard Schilke
Alcohol-based hand disinfection is the key measure to prevent healthcare-associated infections and nosocomial transmission of pathogens. We conducted a survey among dental students, trainee nurses and medical technical assistants in training from the Generation Z to determine their knowledge regarding hand hygiene and to optimize education. Overall knowledge was worthy of improvement. Females performed better than males. Specifically tailored efforts seem necessary to increase hand hygiene competence in the Generation Z.

7 April 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BPBéke Pannewick
Béke Pannewick
CBClaas Baier
Claas Baier
FSFrank Schwab
Frank Schwab
RVRalf-Peter Vonberg
Ralf-Peter Vonberg
There is a lack of data on factors that contribute to the implementation of hygiene measures during nosocomial outbreaks (NO) caused by Methicillin-resistantStaphylococcus aureus(MRSA). Therefore, we first conducted a systematic literature analysis to identify MRSA outbreak reports. The expenditure for infection control in each outbreak was then evaluated by a weighted cumulative hygiene score (WCHS). Effects of factors on this score were determined by multivariable linear regression analysis. 104 NO got included, mostly from neonatology (n = 32), surgery (n = 27), internal medicine and burn units (n = 10 each), including 4,361 patients (thereof 657 infections and 73 deaths) and 279 employees. The outbreak sources remained unknown in 10 NO and were not reported from further 61 NO. The national MRSA prevalence did not correlate with the WCHS (p = .714). There were significant WCHS differences for internal medicine (p = 0.014), burn units (p<0.01), for Japanese NO (p<0.01), and NO with an unknown source (p<0.01). In sum, management of a NO due to MRSA does not depend on the local MRSA burden. However, differences of MRSA management among medical departments do exist. Strict adherence to the Outbreak Reports and Intervention Studies Of Nosocomial infection (ORION) statement is highly recommended for. The WCHS may also serve as a useful tool to quantify infection control effort and could therefore be used for further investigations.

1 September 2020 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
PCPatrick Chhatwal
Patrick Chhatwal
EEElla Ebadi
Ella Ebadi
FTFelicitas Thol
Felicitas Thol
CKChristian Koenecke
Christian Koenecke
GBGernot Beutel
Gernot Beutel
CBClaas Baier
Claas Baier
Vancomycin-resistant enterococci (VRE) are emerging multidrug-resistant bacteria. They can cause serious nosocomial infections, especially in immunocompromised patients. In this study, we aimed to determine the burden of intestinal VRE colonization and clinically relevant infection in adult hematologic and oncologic patients at a tertiary care clinic in Germany based on prospective infection surveillance and an active screening program. In a 12 month period, 132 of 555 patients had intestinal VRE-colonization (23.8%) and four patients (0.7% of the entire cohort, and 3.0% of those colonized with VRE) developed a nosocomial infection with VRE. The prospective surveillance and active screening for VRE was very useful to determine the true ratio of intestinal colonization to infection and thus helps to shape infection control management.

21 October 2019 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
CBClaas Baier
Claas Baier
MBMaleen Beck
Maleen Beck
VPViktoria Panagiota
Viktoria Panagiota
CLCatherina Lueck
Catherina Lueck
DKDaniel Kharazipour
Daniel Kharazipour
GBGernot Beutel
Gernot Beutel
Hematopoietic stem cell transplantation (HSCT) is a curative treatment option for selected diseases of the hematopoietic system. In the context of HSCT, bloodstream infections caused by Gram-negative bacteria (GNB) significantly contribute to morbidity and mortality. Antibiotic treatment of bloodstream infections with carbapenem-resistant (CR) GNB presents a particular challenge. As a part of our infection control management, the admission of a patient who was known to be colonized with a CR Acinetobacter baumannii triggered an active weekly screening of all patients to determine the prevalence and potential transmission of CR GNB and CR Acinetobacter baumannii in particular. Over a 3 month period a total of 71 patients were regularly screened for colonization with CR GNB. Including the index patient, a total of three patients showed CR GNB colonization representing a prevalence of 4.2%. Nosocomial transmission of CR Acinetobacter baumannii or other CR GNB was not observed. However, the index patient developed a subsequent bloodstream infection with the CR Acinetobacter baumannii, therefore empiric antibiotic therapy based on the known resistance profile was initiated. A weekly prevalence screening for CR GNB might be an effective monitoring tool for potential transmission, may enhance existing infection control management concepts and may support the decision making for empiric antibiotic therapy.

27 November 2021 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
PCPatrick Chhatwal
Patrick Chhatwal
EEElla Ebadi
Ella Ebadi
FSFrank Schwab
Frank Schwab
SZStefan Ziesing
Stefan Ziesing
RVRalf-Peter Vonberg
Ralf-Peter Vonberg
CBClaas Baier
Claas Baier
Carbapenem resistant (CR) Klebsiella pneumoniae (Kp) and Acinetobacter baumannii (Ab) are emerging multidrug resistant bacteria with very limited treatment options in case of infection. Both are well-known causes of nosocomial infections and outbreaks in healthcare facilities. A retrospective study was conducted to investigate the epidemiology of inpatients with CR Kp and CR Ab in a 1500-bed German university hospital from 2015 to 2019. We present our infection control concept including a weekly microbiologic screening for patients who shared the ward with a CR Kp or CR Ab index patient. Within 5 years, 141 CR Kp and 60 CR Ab cases were hospitalized corresponding to 118 unique patients (74 patients with CR Kp, 39 patients with CR Ab and 5 patients with both CR Ab and CR Kp). The mean incidence was 0.045 (CR Kp) and 0.019 (CR Ab) per 100 inpatient cases, respectively. Nosocomial acquisition occurred in 53 cases (37.6%) of the CR Kp group and in 12 cases (20.0%) of the CR Ab group. Clinical infection occurred in 24 cases (17.0%) of the CR Kp group and in 21 cases (35.0%) of the CR Ab group. 14 cases (9.9%) of the CR Kp group and 29 cases (48.3%) of the CR Ab group had a history of a hospital stay abroad within 12 months prior to admission to our hospital. The weekly microbiologic screening revealed 4 CR Kp cases caused by nosocomial transmission that would have been missed without repetitive screening. CR Kp and CR Ab cases occurred infrequently. A history of a hospital stay abroad, particularly in the CR Ab group, warrants pre-emptive infection control measures. The weekly microbiologic screening needs further evaluation in terms of its efficiency.